1. Susan, K.S. (2011) TRIPS was never enough: Vertical forum shifting, FTAs, ACTA, and TPP. Journal of Intellectual Property Law 18 (2): 447–478.
2. Malpani, R. (2007) All cost no benefit: How TRIPS-Plus intellectual property rules in the US-Jordan FTA affect access to medicines. Oxford, UK: Oxfam International. Oxfam Briefing Paper No. 102,
http://donttradeourlivesaway.files.wordpress.com/2011/01/all-costs-no-benefits.pdf
, accessed 19 February 2013.
3. Nusaraporn, K., Jiraporn, L., Vidhaya, K., Usawadee, M., Achara, E. and Prinya, P. (2010) Impact on access to medicines from TRIPS-PLUS: A case study of Thai-US FTA. Southeast Asian Journal of Tropical Medicine Public Health 41 (3): 667–677.
4. United Nations. (2001) World Population Ageing 1950-2050. New York: Population Division, DESA, United Nations.
5. World Health Organization. (2011) Global Status Report on Noncommunicable Diseases 2010. Geneva, Switzerland: World Health Organization.